Sofosbuvir and velpatasvir and Xultophy 100/3.6
Determining the interaction of Sofosbuvir and velpatasvir and Xultophy 100/3.6 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sofosbuvir / velpatasvir
Brand name: Epclusa
Synonyms: Sofosbuvir and Velpatasvir
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Xultophy
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sofosbuvir and velpatasvir-Xuriden
- Sofosbuvir and velpatasvir-Xylocaine
- Sofosbuvir and velpatasvir-Xylocaine (Cardiac)
- Sofosbuvir and velpatasvir-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- Sofosbuvir and velpatasvir-Xylocaine (Lidocaine Oral Liquid and Solution)
- Sofosbuvir and velpatasvir-Xylocaine Dental
- Xultophy 100/3.6-Sofosbuvir Tablets
- Xultophy 100/3.6-Sofosbuvir, velpatasvir, and voxilaprevir
- Xultophy 100/3.6-Sojourn
- Xultophy 100/3.6-Sojourn Inhalant
- Xultophy 100/3.6-Solage
- Xultophy 100/3.6-Solage Topical